Both NVP-BEZ235 and AZD8055 treatments of Lkb1−/−NIC mice reduced the tumor volume compared with the vehicle control, though AZD8055 treatment inhibited the tumor volume significantly more compared with NVP-BEZ235 treatment [151]. This evidence concerns the gene STK11 and neoplasm.